Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking approach to diabetes management. These innovative drugs operate by mimicking the inherent actions of GLP-1, a hormone released by the gut in https://agendabookmarks.com/story20707927/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes